Cargando…
Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification
BACKGROUND: Phosphate (Pi) toxicity is a strong determinant of vascular calcification development in chronic kidney disease (CKD). Magnesium (Mg(2+)) may improve cardiovascular risk via vascular calcification. The mechanism by which Mg(2+) counteracts vascular calcification remains incompletely desc...
Autores principales: | ter Braake, Anique D, Eelderink, Coby, Zeper, Lara W, Pasch, Andreas, Bakker, Stephan J L, de Borst, Martin H, Hoenderop, Joost G J, de Baaij, Jeroen H F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203562/ https://www.ncbi.nlm.nih.gov/pubmed/31605492 http://dx.doi.org/10.1093/ndt/gfz190 |
Ejemplares similares
-
Calciprotein Particle Synthesis Strategy Determines In Vitro Calcification Potential
por: Zeper, Lara W., et al.
Publicado: (2022) -
Magnesium to prevent kidney disease–associated vascular calcification: crystal clear?
por: ter Braake, Anique D, et al.
Publicado: (2020) -
Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation
por: ter Braake, Anique D., et al.
Publicado: (2018) -
Low plasma magnesium concentration and future abdominal aortic calcifications in moderate chronic kidney disease
por: ter Braake, Anique D., et al.
Publicado: (2021) -
Regulation of magnesium balance: lessons learned from human genetic disease
por: de Baaij, Jeroen H. F., et al.
Publicado: (2012)